Le Lézard
Classified in: Health
Subject: LBR

TEAMSTERS AT DETROIT MEDICAL CENTER TO RALLY DURING DETROIT CHAMBER OF COMMERCE MEETING


Following Strike Vote, Teamsters Demand DMC Bargain in Good Faith

BIRMINGHAM, Mich., Sept. 6, 2023 /PRNewswire/ -- Lab assistants and customer service representatives with Teamsters Local 283 will rally outside a Detroit Regional Chamber of Commerce meeting on September 7. In attendance at the meeting will be Detroit Medical Center CEO Brittany Lavis and members of Congress that represent Southeastern Michigan.

Teamsters are demanding that DMC management negotiate in good faith and offer workers a living wage and affordable, quality health care.

Over the last several months, negotiations between Local 283 and DMC have grown contentious. Teamsters voted overwhelmingly to authorize a strike in late September if an agreement is not reached.

WHO:


Detroit Medical Center workers; Local 283 members




WHEN:


Thursday, September 7, 11 a.m.-1 p.m. ET




WHERE:


The Townsend Hotel



100 Townsend St.



Birmingham, MI




Contact:
Kate Yeager 
[email protected]

SOURCE Teamsters Local 283


These press releases may also interest you

at 02:43
Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET. A combined audio cast and telephone conference with the opportunity to ask questions will be...

at 02:39
This announcement summarizes Bioretec Ltd's business review for January-March 2024. The complete business review is attached to this release as a PDF file and available on the company's website at...

at 01:50
SHL Telemedicine Ltd. ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is thrilled to announce that it recently officially launched it's SmartHeart® membership program in the US. This...

at 01:30
XRP Healthcare proudly announces its sponsorship of the upcoming Ehlers-Danlos Society event in Philadelphia this July 17th ? 21st....

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase Ib clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of obesity and type 2 diabetes. The...

at 00:00
Author Kory L. Wilson and his family have experienced the benefits of information he shares in Home Remedies: A Guidebook To Breaking Away From Big Pharma ($15.99, paperback, 9781662896668; $6.99, e-book, 9781662896675). For years, I have collected...



News published on and distributed by: